Correct, it is old news. Share price digested it long ago.
Since then, trial news has been really positive across the board and Immutep has largely de-risked since the Fast Track ann with Keytruda.
I don’t know about sky rocketing just yet( positive results are expected and won’t surprise the market) but the company remains good value(imo) with a solid upward share price trend showing good rising support levels over an extended period, including a large capital raise.
At some point the share price will re-rate over the next 12 months, that’s my opinion. Whether that happens steadily or in a sky rocket is anyone’s guess.
Media, page-313
-
- There are more pages in this discussion • 431 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |